Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Pemphigus therapy with oral prednisolone regimens. A 5-year study.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Ratnam KV;Ratnam KV; Phay KL; Tan CK
- Source:
International journal of dermatology [Int J Dermatol] 1990 Jun; Vol. 29 (5), pp. 363-7.
- Publication Type:
Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
- Language:
English
- Additional Information
- Source:
Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print Cited Medium: Print ISSN: 0011-9059 (Print) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE
- Publication Information:
Publication: Oxford : Blackwell Science
Original Publication: Philadelphia, Lippincott.
- Subject Terms:
- Abstract:
Twenty-two newly diagnosed patients with pemphigus were randomly divided into two groups of 11 each. One group was placed on a high-dose prednisolone (120 mg/day) therapy and the other group on a low-dose (60 mg/day) therapy. The patients were followed for 5 years. Although a rapid initial control of the pemphigus appeared to be achieved with the high-dose regimen, this regimen did not have any long-term benefit over the low-dose regimen with respect to the frequency of relapse or in the incidence of complications.
- Accession Number:
8N3DW7272P (Cyclophosphamide)
9PHQ9Y1OLM (Prednisolone)
YL5FZ2Y5U1 (Methotrexate)
- Publication Date:
Date Created: 19900601 Date Completed: 19900806 Latest Revision: 20190722
- Publication Date:
20240829
- Accession Number:
10.1111/j.1365-4362.1990.tb04765.x
- Accession Number:
2361795
No Comments.